Causal Inference in Real World Evidence: What is it? Why now?

1 minute read

Published: January 22nd, 2026

Causal inference is increasingly used to generate real-world evidence (RWE), by regulatory bodies and health technology assessment.

This webinar introduces what is required to support causal claims, how causality can be evaluated across different study designs, and why this shift is particularly relevant for RWE today.  

Speakers:
  • Ryan Batten, Senior Statistician
  • Josh Enxing, Senior Programmer- Moderator
Learning Points:
  • Distinguishing correlation from causation in the context of clinical and real-world data (RWD).
  • When do we currently use causality? Examples of how it is currently used (i.e., RCTs). Sometimes this is not explicitly stated but implied.
  • Why now? Advances in causal methods and the growing regulatory/HTA reliance on RWE make explicit causal intent essential, as it fundamentally shapes study design, analysis planning, and interpretation.
Complete the form below to access the recording and slides:

Related articles

Regulatory-Grade Use of External Data: Bayesian Borrowing, Hybrid Trials and External Controls 

Regulatory-Grade Use of External Data: Bayesian Borrowing, Hybrid Trials and External Controls 

November 20th, 2025 1 minute read

Use of external data to augment clinical trials has been increasingly evaluated and is transforming drug development ...

SDTM Workflow Transformation: Faster, Easier and More Reliable

SDTM Workflow Transformation: Faster, Easier and More Reliable

November 14th, 2025 1 minute read

The demand for rapid, cost-effective, and standards-compliant SDTM delivery continues to increase across the biotech ...

Early Phase Clinical Trials: Key Considerations for Drug Development Pipelines

Early Phase Clinical Trials: Key Considerations for Drug Development Pipelines

October 30th, 2025 1 minute read

The early stages of clinical development are critical, decisions made here can determine the efficiency, cost, and ul...